Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the metabolic and cardiovascular effects of
pioglitazone, once daily (QD), and insulin combination therapy in subjects with Type 2
Diabetes and Renal Failure.